BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21795823)

  • 1. Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A(H1N1)v severe pneumonia.
    Estella A
    J Infect Dev Ctries; 2011 Jul; 5(7):540-3. PubMed ID: 21795823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory profiles in severe pneumonia associated with the pandemic influenza A/H1N1 virus isolated in Mexico City.
    Zúñiga J; Torres M; Romo J; Torres D; Jiménez L; Ramírez G; Cruz A; Espinosa E; Herrera T; Buendía I; Ramírez-Venegas A; González Y; Bobadilla K; Hernández F; García J; Quiñones-Falconi F; Sada E; Manjarrez ME; Cabello C; Kawa S; Zlotnik A; Pardo A; Selman M
    Autoimmunity; 2011 Nov; 44(7):562-70. PubMed ID: 21838592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.
    Montón C; Torres A; El-Ebiary M; Filella X; Xaubet A; de la Bellacasa JP
    Crit Care Med; 1999 Sep; 27(9):1745-53. PubMed ID: 10507593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema.
    Schütte H; Lohmeyer J; Rosseau S; Ziegler S; Siebert C; Kielisch H; Pralle H; Grimminger F; Morr H; Seeger W
    Eur Respir J; 1996 Sep; 9(9):1858-67. PubMed ID: 8880103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09.
    Martinez-Ocaña J; Olivo-Diaz A; Salazar-Dominguez T; Reyes-Gordillo J; Tapia-Aquino C; Martínez-Hernández F; Manjarrez ME; Antonio-Martinez M; Contreras-Molina A; Figueroa-Moreno R; Valdez-Vazquez R; Kawa-Karasik S; Rodríguez-Zulueta P; Flisser A; Maravilla P; Romero-Valdovinos M
    J Clin Virol; 2013 Sep; 58(1):108-13. PubMed ID: 23809475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine and chemokine responses in pediatric patients with severe pneumonia associated with pandemic A/H1N1/2009 influenza virus.
    Matsumoto Y; Kawamura Y; Nakai H; Sugata K; Yoshikawa A; Ihira M; Ohashi M; Kato T; Yoshikawa T
    Microbiol Immunol; 2012 Sep; 56(9):651-5. PubMed ID: 22734496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammatory response after bronchoalveolar lavage in critically ill patients.
    Bauer TT; Arosio C; Montón C; Filella X; Xaubet A; Torres A
    Eur Respir J; 2001 Feb; 17(2):274-80. PubMed ID: 11334131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection.
    Takano T; Tajiri H; Kashiwagi Y; Kimura S; Kawashima H
    Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):117-20. PubMed ID: 20820834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia.
    Kolsuz M; Erginel S; Alataş O; Alataş F; Metintaş M; Uçgun I; Harmanci E; Colak O
    Respiration; 2003; 70(6):615-22. PubMed ID: 14732793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza A in the Tokyo area.
    Terai M; Honda T; Yamamoto S; Yoshida M; Tsuchiya N; Moriyama Y; Matsui T; Tokutake S; Suzuki E; Shirato Y; Muto A; Hayashi K; Hamada H
    Microbiol Immunol; 2011 May; 55(5):341-6. PubMed ID: 21323726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammatory cytokine-mediated response after bronchoalveolar lavage in mechanically ventilated patients with suspected pneumonia.
    Estella A; Jareño A
    J Bronchology Interv Pulmonol; 2012 Apr; 19(2):102-8. PubMed ID: 23207351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profile of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during seasonal H1N1 infection.
    Hasegawa S; Wakiguchi H; Okada S; Gui Kang Y; Fujii N; Hasegawa M; Hasegawa H; Ainai A; Atsuta R; Shirabe K; Toda S; Wakabayashi-Takahara M; Morishima T; Ichiyama T
    Cytokine; 2014 Oct; 69(2):206-10. PubMed ID: 24998935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.
    Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadière B; van der Werf S; Autran B; Carcelain G;
    Am J Respir Crit Care Med; 2014 May; 189(10):1240-9. PubMed ID: 24646009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.
    Viasus D; Cordero E; Rodríguez-Baño J; Oteo JA; Fernández-Navarro A; Ortega L; Gracia-Ahufinger I; Fariñas MC; García-Almodovar E; Payeras A; Paño-Pardo JR; Muñez-Rubio E; Carratalà J;
    Clin Microbiol Infect; 2012 Mar; 18(3):E55-62. PubMed ID: 22264321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.
    Hagau N; Slavcovici A; Gonganau DN; Oltean S; Dirzu DS; Brezoszki ES; Maxim M; Ciuce C; Mlesnite M; Gavrus RL; Laslo C; Hagau R; Petrescu M; Studnicska DM
    Crit Care; 2010; 14(6):R203. PubMed ID: 21062445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection.
    Kim YH; Kim JE; Hyun MC
    Pediatr Pulmonol; 2011 Dec; 46(12):1233-9. PubMed ID: 21626718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.
    Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM
    J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.
    Gauger PC; Vincent AL; Loving CL; Henningson JN; Lager KM; Janke BH; Kehrli ME; Roth JA
    Vet Pathol; 2012 Nov; 49(6):900-12. PubMed ID: 22461226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia.
    Rendón-Ramirez EJ; Ortiz-Stern A; Martinez-Mejia C; Salinas-Carmona MC; Rendon A; Mata-Tijerina VL; Rosas-Taraco AG
    Viral Immunol; 2015 Jun; 28(5):248-54. PubMed ID: 25923384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.